First Swedish Patient Starts Leqembi Alzheimer's Treatment at Stockholm Clinic

Bioarctic announced the first Swedish patient has begun treatment with Leqembi at Executive Health in Stockholm. This marks the drug's clinical rollout in Sweden, though it is a single patient event with no efficacy or safety data disclosed. The development signals commercial adoption of the Alzheimer's therapy in a new market.